Table 3.
subgroup analysis of the included studies for outcome oligodendrocyte precursor cell counts.
Subgroup | Comparisons | Effect estimate [95% CI] | I2 |
---|---|---|---|
Overall | 34 | 0.87 [−0.08, 1.83] | 92% |
Therapeutic regimen | |||
therapeutically | 29 | 1.31 [0.25, 2.37] | 93% |
Method | |||
PDGFRα | 13 | 2.50 [0.51, 4.49] | 94% |
The effect estimate was displayed by the standardized mean difference (SMD) and 95% confidence intervals (CIs). No significant differences were found in the subgroup analyses.